Scholarly Works per year
Scholarly Works per year
Fingerprint
Dive into the research topics where Monika Schmelz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression
Sarwar, S., Tome, M. E., Billheimer, D., Spier, C., Smith, C. L., Persky, D. & Schmelz, M., 2024, In: Histology and Histopathology. 39, 3, p. 319-331 13 p.Research output: Contribution to journal › Article › peer-review
-
Letter to the Editor: Validation of Biorepository Quality - Accreditation
Schmelz, M. & Silver, S., Apr 1 2023, In: Biopreservation and Biobanking. 21, 2, p. 217-218 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
The AIDS and Cancer Specimen Resource (ACSR): HIV malignancy specimens and data available at no cost
Silver, S. & Schmelz, M., Dec 2023, In: AIDS Research and Therapy. 20, 1, 61.Research output: Contribution to journal › Review article › peer-review
Open Access -
Biorepository best practices for research and clinical investigations
Sanderson-November, M., Silver, S., Hooker, V. & Schmelz, M., May 2022, In: Contemporary Clinical Trials. 116, 106572.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A plan for emergency shutdown and reopening for a consortium of biobanks
Schmelz, M., Sanderson-November, M., Humeida, R., Cloete, M., Mims, M., Castro, P., Leong, A., Wisner, L. & Silver, S., Oct 2021, In: Biopreservation and Biobanking. 19, 5, p. 394-398 5 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Datasets
-
Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D. (Creator), Guillén-Rodríguez, J. M. (Creator), Rivera, X. I. (Creator), Heard, K. (Creator), Inclan, L. (Creator), Schmelz, M. (Creator), Schatz, J. H. (Creator) & Persky, D. O. (Creator), figshare, 2017
DOI: 10.6084/m9.figshare.5373199, https://karger.figshare.com/articles/figure/Supplementary_Material_for_A_Phase_II_Exploratory_Study_of_PXD-101_Belinostat_Followed_by_Zevalin_in_Patients_with_Relapsed_Aggressive_High-Risk_Lymphoma/5373199
Dataset
-
Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D. (Creator), Guillén-Rodríguez, J. M. (Creator), Rivera, X. I. (Creator), Heard, K. (Creator), Inclan, L. (Creator), Schmelz, M. (Creator), Schatz, J. H. (Creator) & Persky, D. O. (Creator), Karger Publishers, 2017
DOI: 10.6084/m9.figshare.5373199.v1, https://karger.figshare.com/articles/figure/Supplementary_Material_for_A_Phase_II_Exploratory_Study_of_PXD-101_Belinostat_Followed_by_Zevalin_in_Patients_with_Relapsed_Aggressive_High-Risk_Lymphoma/5373199/1
Dataset